Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology

Emeric Boisteau1,2, Céline Posseme1,3, Federico Di Modugno1,3

  • 1INSERM U1242, University of Rennes, Rennes, France.

Oncogene
|September 6, 2022
PubMed

Insights

Anterior gradient (AGR) proteins, particularly AGR2, are crucial in digestive tract health and disease. Their roles in inflammation and cancer suggest potential as therapeutic targets for digestive disorders.

Area of Science:

  • Cell Biology
  • Gastroenterology
  • Oncology

Background:

  • Secretory epithelia in the digestive tract rely on specialized molecular machines.
  • Anterior gradient (AGR) proteins (AGR1, AGR2, AGR3) are part of the protein disulfide isomerase family.
  • These proteins are vital for secretory and transmembrane protein biogenesis in the endoplasmic reticulum.

Purpose of the Study:

  • To review the known roles and mechanisms of AGR proteins in digestive diseases.
  • To examine AGR protein expression in healthy digestive tracts and digestive cancers.
  • To discuss the diagnostic and therapeutic implications of AGR protein biology.

Main Methods:

  • Literature review of existing research on AGR proteins.
  • Analysis of AGR protein expression patterns in healthy and diseased digestive tissues.
  • Synthesis of data on AGR protein functions in inflammation and oncogenesis.

Main Results:

  • AGR proteins are highly expressed in digestive tract epithelia.
  • AGR2 is extensively studied, showing diverse subcellular localizations and pro-oncogenic functions.
  • AGR2 overexpression correlates with poor prognosis in digestive cancers and plays a role in gut inflammation and homeostasis.

Conclusions:

  • AGR2 is implicated in both inflammation and oncogenesis within the digestive system.
  • Dysregulation of AGR proteins contributes to digestive diseases.
  • AGR proteins represent promising targets for future diagnostic and therapeutic strategies in gastroenterology and oncology.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.1K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K